Authors: SCOTT CB SCARANTINO C URTASUN R MOVSAS B JONES CU SIMPSON JR FISCHBACH AJ CURRAN WJ

Citation: Cb. Scott et al., VALIDATION AND PREDICTIVE POWER OF RADIATION-THERAPY ONCOLOGY GROUP (RTOG) RECURSIVE PARTITIONING ANALYSIS CLASSES FOR MALIGNANT GLIOMA PATIENTS - A REPORT USING RTOG-90-06, International journal of radiation oncology, biology, physics, 40(1), 1998, pp. 51-55

Authors: PHUPHANICH S SCOTT C FISCHBACH AJ LANGER C YUNG WKA

Citation: S. Phuphanich et al., ALL-TRANS-RETINOIC ACID - A PHASE-II RADIATION-THERAPY ONCOLOGY GROUP-STUDY (RTOG-91-13) IN PATIENTS WITH RECURRENT MALIGNANT ASTROCYTOMA, Journal of neuro-oncology, 34(2), 1997, pp. 193-200

Authors: SIMPSON JR SCOTT CB ROTMAN M CURRAN WJ CONSTINE LS FISCHBACH AJ ASBELL SO

Citation: Jr. Simpson et al., RACE AND PROGNOSIS OF BRAIN-TUMOR PATIENTS ENTERING MULTICENTER CLINICAL-TRIALS - A REPORT FROM THE RADIATION-THERAPY ONCOLOGY GROUP, American journal of clinical oncology, 19(2), 1996, pp. 114-120

Authors: MURRAY KJ NELSON DF SCOTT C FISCHBACH AJ PORTER A FARNAN N CURRAN WJ

Citation: Kj. Murray et al., QUALITY-ADJUSTED SURVIVAL ANALYSIS OF MALIGNANT GLIOMA, PATIENTS TREATED WITH TWICE-DAILY RADIATION (RT) AND CARMUSTINE - A REPORT OF RADIATION-THERAPY ONCOLOGY GROUP (RTOG)-83-02, International journal of radiation oncology, biology, physics, 31(3), 1995, pp. 453-459

Authors: CURRAN WJ SCOTT CB HORTON J NELSON JS WEINSTEIN AS FISCHBACH AJ CHANG CH ROTMAN M ASBELL SO KRISCH RE NELSON DF

Citation: Wj. Curran et al., RECURSIVE PARTITIONING ANALYSIS OF PROGNOSTIC FACTORS IN 3 RADIATION-THERAPY ONCOLOGY GROUP MALIGNANT GLIOMA TRIALS, Journal of the National Cancer Institute, 85(9), 1993, pp. 704-710

Authors: CURRAN WJ SCOTT CB WEINSTEIN AS MARTIN LA NELSON JS PHILLIPS TL MURRAY K FISCHBACH AJ YAKAR D SCHWADE JG CORN B NELSON DF

Citation: Wj. Curran et al., SURVIVAL COMPARISON OF RADIOSURGERY-ELIGIBLE AND RADIOSURGERY-INELIGIBLE MALIGNANT GLIOMA PATIENTS TREATED WITH HYPERFRACTIONATED RADIATION-THERAPY AND CARMUSTINE - A REPORT OF RADIATION-THERAPY ONCOLOGY GROUP-83-02, Journal of clinical oncology, 11(5), 1993, pp. 857-862